(S)-TERT-BUTYL 3-(3-METHOXY-3-OXOPROPANOYL)PIPERIDINE-1-CARBOXYLATE, 90.0%, 250mg

5-chloro-1-(4-iodophenyl)-1-oxopentane, 95.0%, 1g

2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

Solution d'hydroxyde de sodium, ROTI®Volum 0,5 mol/l - 0,5 N, ampoule, 1 pièce, emballage plastique.

6-(Methylsulfonyl)-1H-indole, 95.0%, 250mg

4-Bromo-2-(trifluoromethoxy)aniline>98.0%(GC)25g

Bis(4-Nitrophenyl)carbonate, 99.0%, 500g

tert-Butyl (3-aminopyridin-2-yl)carbamate, 95.0%, 2.5g

METHYL 2-(2-FLUORO-5-NITROPHENYL)ACETATE, 1g

[(2E)-2-methyl-3-phenylprop-2-en-1-yl](prop-2-en-1-yl)amine hydrochloride, 95.0%, 1g

6-Hydroxy-2-(1-methylethylidene)-1-benzofuran-3(2H)-one, 95.0%, 1g

2-Amino-N-(2-(dimethylamino)ethyl)-2-methylpropanamide dihydrochloride, 97%, 100mg

Acetyl-5-hydroxy-tryptamine, 98.0%, 250mg